文献速递肝病消化道肿瘤与早癌

人CD127+固有淋巴细胞单细胞图谱揭示肝细胞癌多样免疫表型

Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma.
PubMed 文献 · Hepatology · 2022-03-25

研究对肝细胞癌患者分选的肝脏固有淋巴细胞(ILC)行单细胞RNA测序,并用流式细胞术、多重免疫荧光及功能实验验证。共鉴定3433个ILC中的7个亚群,ICOS+ ILC2a在肝细胞癌中富集并与不良预后相关;B细胞来源ICOSL信号通过增加IL-13促进ICOS+ ILC2a炎症分化;靶向ICOS及其下游HSP70可抑制肿瘤生长并重塑免疫抑制微环境。

要点

  • 肝细胞癌中ILC失调表现为细胞数量或亚群比例改变,共鉴定7个ILC亚群。
  • ICOS+ ILC2a在肝细胞癌中优先富集,并与不良预后相关。
  • B细胞来源ICOSL信号通过增加IL-13促进ICOS+ ILC2a炎症分化。

核心结论

  • B细胞驱动的2型天然炎症在肝细胞癌中发挥作用,靶向ILC2的ICOS及其下游HSP70为肝细胞癌免疫治疗提供潜在策略。

研究设计与样本

  • 对肝细胞癌患者分选的肝脏ILC细胞行单细胞RNA测序分析,并用流式细胞术、多重免疫荧光染色及功能实验验证。
  • 采用选择策略富集肝细胞癌样本中的ILC群体,以研究B细胞对ICOS+ ILC2细胞免疫反应的影响。

主要发现

  • 在3433个ILC中鉴定出7个具有独特性质的亚群,ICOS+ ILC2a在肝细胞癌中优先富集并与不良预后相关。
  • B细胞尤其是静息初始B细胞参与ILC2细胞的炎症分化,B细胞来源ICOSL信号通过增加ICOS+ ILC2a细胞产生IL-13加剧炎症。
  • HSP70基因HSPA1A和HSPA1B在晚期肝细胞癌ILC2中高表达,靶向ILC2的ICOS及其下游HSP70可抑制肿瘤生长并重塑免疫抑制肿瘤微环境。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that play critical roles in cytokine-mediated regulation of homeostasis and inflammation. However, relationships between their immune phenotypic characteristics and HCC remain largely unexplored. APPROACH AND RESULTS: We performed single-cell RNA sequencing analysis on sorted hepatic ILC cells from human patients with HCC and validated using flow cytometry, multiplex immunofluorescence staining, and functional experiments. Moreover, we applied selection strategies to enrich ILC populations in HCC samples to investigate the effects of B cells on the immune reaction of inducible T cell costimulator (ICOS)+ ILC2 cells. Dysregulation of ILCs was manifested by the changes in cell numbers or subset proportions in HCC. Seven subsets of 3433 ILCs were identified with unique properties, of which ICOS+ ILC2a were preferentially enriched in HCC and correlated with poor prognosis. Mechanistically, we report that B cells, particularly resting naïve B cells, have a previously unrecognized function that is involved in inflammatory differentiation of ILC2 cells. B cell-derived ICOSL signaling was responsible for exacerbating inflammation through the increased production of IL-13 in ICOS+ ILC2a cells. Heat shock protein 70 (HSP70) genes Heat Shock Protein Family A Member 1A (HSPA1A) and Heat Shock Protein Family A Member 1B (HSPA1B) were highly expressed in ILC2s in late-stage HCC, and targeting to ICOS and its downstream effector HSP70 in ILC2s suppressed tumor growth and remodeled the immunosuppressive tumor microenvironment. CONCLUSIONS: This in-depth understanding sheds light on B cell-driven innate type 2 inflammation and provides a potential strategy for HCC immunotherapy.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. He Y, Luo J, Zhang G, et al. Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. Hepatology. 2022. PMID: 35243668. doi:10.1002/hep.32444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。